Nucl Med Commun. 2007 May;28(5):335-54.

The role of FDG PET in the management of lymphoma: what is the evidence base?

Source

Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, UK. annakirby@doctors.org.uk

Abstract

[18F]Fluorodeoxyglucose positron emission tomography (18F-FDG PET) is playing an increasing role in the management of both Hodgkin and non-Hodgkin lymphoma, offering potential advantages in the accuracy of disease assessment at a number of points in the management pathway. This review evaluates the current level of confidence in the use of PET technology in (1) initial staging, (2) the assessment of early response to chemotherapy, (3) the assessment of residual masses at completion of initial treatment, (4) follow-up, and (5) radiotherapy planning.

PMID:: 17414883; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Education

New England Research Institutes Inc.

Medical

Supplemental Content

Save items

Related citations in PubMed

Review The role of FDG PET in the management of lymphoma: practical guidelines. [Nucl Med Commun. 2007]
Review The role of FDG PET in the management of lymphoma: practical guidelines.
Kirby AM, George Mikhaeel N. Nucl Med Commun. 2007 May; 28(5):355-7.
18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative? [J Nucl Med. 2007]
18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?
Weber WA. J Nucl Med. 2007 Oct; 48(10):1580-2.
Review Evaluation of therapy for lymphoma. [Semin Nucl Med. 2005]
Review Evaluation of therapy for lymphoma.
Jerusalem G, Hustinx R, Beguin Y, Fillet G. Semin Nucl Med. 2005 Jul; 35(3):186-96.
18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence. [Ann Nucl Med. 2008]
18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.
Isohashi K, Tatsumi M, Higuchi I, Inoue A, Nakajo K, Ishikawa J, Shimosegawa E, Kanakura Y, Nakamura H, Hatazawa J. Ann Nucl Med. 2008 Nov; 22(9):795-802. Epub 2008 Nov 28.
Review Impact of fluorodeoxyglucose PET on the management of esophageal cancer. [Nucl Med Commun. 2009]
Review Impact of fluorodeoxyglucose PET on the management of esophageal cancer.
Salavati A, Basu S, Heidari P, Alavi A. Nucl Med Commun. 2009 Feb; 30(2):95-116.

See reviews... See all...

Cited by 5 PubMed Central articles

Accessory spleen-like masses in oncology patients: Are they always benign? [World J Radiol. 2010]
Accessory spleen-like masses in oncology patients: Are they always benign?
Groshar D, Bernstine H, Goldberg N, Stern D, Sosna J. World J Radiol. 2010 Sep 28; 2(9):368-73.
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma. [Haematologica. 2010]
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.
Dann EJ, Bar-Shalom R, Tamir A, Epelbaum R, Avivi I, Ben-Shachar M, Gaitini D, Rowe JM. Haematologica. 2010 Jul; 95(7):1198-206. Epub 2010 Apr 21.
Evaluation of the spatial dependence of the point spread function in 2D PET image reconstruction using LOR-OSEM. [Med Phys. 2010]
Evaluation of the spatial dependence of the point spread function in 2D PET image reconstruction using LOR-OSEM.
Wiant D, Gersh JA, Bennett M, Bourland JD. Med Phys. 2010 Mar; 37(3):1169-82.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The role of FDG PET in the management of lymphoma: what is the evidence base?
The role of FDG PET in the management of lymphoma: what is the evidence base?
Nucl Med Commun. 2007 May ;28(5):335-54.

PubMed
Microvascular soft-tissue transplantation for reconstruction of acute open tibia...
Microvascular soft-tissue transplantation for reconstruction of acute open tibial fractures: timing of coverage and long-term functional results.
Plast Reconstr Surg. 1992 Mar ;89(3):478-87; discussion 488-9.

PubMed
Generation of functional islet-like clusters after monolayer culture and intraca...
Generation of functional islet-like clusters after monolayer culture and intracapsular aggregation of adult human pancreatic islet tissue.
Transplantation. 2007 Mar 27 ;83(6):685-93.

PubMed
Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest an...
Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells.
Anticancer Drugs. 2007 Jun ;18(5):535-41.

PubMed
Gene expression profiles differentiate between sterile SIRS and early sepsis.
Gene expression profiles differentiate between sterile SIRS and early sepsis.
Ann Surg. 2007 Apr ;245(4):611-21.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: